Presence and outcomes of kidney disease in patients with pulmonary hypertension

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 5, 2014, Pages 855-863

  Navaneethan, Sankar D ^a,d   Wehbe, Edgard ^a   Heresi, Gustavo A ^b   Gaur, Varun ^c   Minai, Omar A ^b   Arrigain, Susana ^a   Nally, Joseph V ^a,d   Schold, Jesse D ^a   Rahman, Mahboob ^e   Dweik, Raed A ^b,d  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Respiratory Institute   (United States)

^c Medicine Institute   (United States)

^d CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN;

ADULT; AGE; ARTICLE; CHRONIC KIDNEY DISEASE; COMORBIDITY; DATA COLLECTION METHOD; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GENDER; GLOMERULUS FILTRATION RATE; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT ATRIUM PRESSURE; HUMAN; HYPERTENSION; KAPLAN MEIER METHOD; LOGISTIC REGRESSION ANALYSIS; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PROPORTIONAL HAZARDS MODEL; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY ANALYSIS; STAGING; TREATMENT OUTCOME; AGED; ARTERIAL PRESSURE; CHRONIC KIDNEY FAILURE; LUNG WEDGE PRESSURE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ARTERIAL PRESSURE; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEMOGLOBINS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PULMONARY WEDGE PRESSURE; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 84919617372     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.10191013     Document Type: Article

References (30)

1. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J, Harrington RA, Anderson JL, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Grines CL, Hlatky MA, Jacobs AK, Kaul S, Lichtenberg RC, Lindner JR, Moliterno DJ, Mukherjee D, Pohost GM, Rosenson RS, Schofield RS, Shubrooks SJ, Stein JH, Tracy CM, Weitz HH, Wesley DJ; ACCF/AHA: ACCF/ AHA 2009 expert consensus document on pulmonary hypertension: A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 119: 2250–2294, 2009
2. Heresi GA, Dweik RA: Pulmonary hypertension: Evaluation and management. Compr Ther 33: 150–161, 2007
3. Batal O, Khatib OF, Dweik RA, Hammel JP, McCarthy K, Minai OA: Comparison of baseline predictors of prognosis in pulmonary arterial hypertension in patients surviving #2 years and those surviving $5 years after baseline right-sided cardiac catheterization. Am J Cardiol 109: 1514–1520, 2012
4. Di Lullo L, Floccari F, Rivera R, Barbera V, Granata A, Otranto G, Mudoni A, Malaguti M, Santoboni A, Ronco C: Pulmonary hypertension and right heart failure in chronic kidney disease: New challenge for 21st-century cardionephrologists. Cardiorenal Med 3: 96–103, 2013
5. Haddad F, Fuh E, Peterson T, Skhiri M, Kudelko KT, De Jesus Perez V, Winkelmayer WC, Doyle RL, Chertow GM, Zamanian RT: Incidence, correlates, and consequences of acute kidney injury in patients with pulmonary arterial hypertension hospitalized with acute right-side heart failure. J Card Fail 17: 533–539, 2011
6. Waxman AB, Zamanian RT: Pulmonary arterial hypertension: New insights into the optimal role of current and emerging prostacyclin therapies. Am J Cardiol 111[5 Suppl]: 1A–16A, 2013
7. Fishman AP: Clinical classification of pulmonary hypertension. Clin Chest Med 22: 385–391, 2001
8. Guazzi M, Borlaug BA: Pulmonary hypertension due to left heart disease. Circulation 126: 975–990, 2012
9. Hansdottir S, Groskreutz DJ, Gehlbach BK: WHO’s in second?: A practical review of World Health Organization group 2 pulmonary hypertension. Chest 144: 638–650, 2013
10. Park M, Hsu CY, Li Y, Mishra RK, Keane M, Rosas SE, Dries D, Xie D, Chen J, He J, Anderson A, Go AS, Shlipak MG; Chronic Renal Insufficiency Cohort (CRIC) Study Group: Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol 23: 1725–1734, 2012
11. Lam CS, Roger VL, Rodeheffer RJ, Borlaug BA, Enders FT, Redfield MM: Pulmonary hypertension in heart failure with preserved ejection fraction: A community-based study. J Am Coll Cardiol 53: 1119–1126, 2009
12. Howard LS: Prognostic factors in pulmonary arterial hypertension: Assessing the course of the disease. Eur Respir Rev 20: 236–242, 2011
13. Humbert M, Sitbon O, Yaïci A, Montani D, O’Callaghan DS, Jaïs X, Parent F, Savale L, Natali D, Günther S, Chaouat A, Chabot F, Cordier JF, Habib G, Gressin V, Jing ZC, Souza R, Simonneau G; French Pulmonary Arterial Hypertension Network: Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J 36: 549–555, 2010
14. Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, Frost A, Barst RJ, Badesch DB, Elliott CG, Liou TG, McGoon MD: Predicting survival in pulmonary arterial hypertension: Insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL). Circulation 122: 164–172, 2010
15. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296–1305, 2004
16. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX: Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol 17: 2034–2047, 2006
17. Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A, McGoon M, Naeije R, Olschewski H, Oudiz RJ, Torbicki A: Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 54[Suppl]: S55–S66, 2009
18. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604–612, 2009
19. Bursi F, McNallan SM, Redfield MM, Nkomo VT, Lam CS, Weston SA, Jiang R, Roger VL: Pulmonary pressures and death in heart failure: A community study. J Am Coll Cardiol 59: 222–231, 2012
20. Agarwal R: Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients. Nephrol Dial Transplant 27: 3908–3914, 2012
21. Sise ME, Courtwright AM, Channick RN: Pulmonary hypertension in patients with chronic and end-stage kidney disease. Kidney Int 84: 682–692, 2013
22. Bolignano D, Rastelli S, Agarwal R, Fliser D, Massy Z, Ortiz A, Wiecek A, Martinez-Castelao A, Covic A, Goldsmith D, Suleymanlar G, Lindholm B, Parati G, Sicari R, Gargani L, Mallamaci F, London G, Zoccali C: Pulmonary hypertension in CKD. Am J Kidney Dis 61: 612–622, 2013
23. Kawar B, Ellam T, Jackson C, Kiely DG: Pulmonary hypertension in renal disease: Epidemiology, potential mechanisms and implications. Am J Nephrol 37: 281–290, 2013
24. Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, Barst RJ, Benza RL, Liou TG, Turner M, Giles S, Feldkircher K, Miller DP, McGoon MD: Pulmonary arterial hypertension: Baseline characteristics from the REVEAL Registry. Chest 137: 376–387, 2010
25. Havlucu Y, Kursat S, Ekmekci C, Celik P, Serter S, Bayturan O, Dinc G: Pulmonary hypertension in patients with chronic renal failure. Respiration 74: 503–510, 2007
26. Shah SJ, Thenappan T, Rich S, Tian L, Archer SL, Gomberg-Maitland M: Association of serum creatinine with abnormal he-modynamics and mortality in pulmonary arterial hypertension. Circulation 117: 2475–2483, 2008
27. Amin M, Fawzy A, Hamid MA, Elhendy A: Pulmonary hypertension in patients with chronic renal failure: Role of parathyroid hormone and pulmonary artery calcifications. Chest 124: 2093–2097, 2003
28. Abdelwhab S, Elshinnawy S: Pulmonary hypertension in chronic renal failure patients. Am J Nephrol 28: 990–997, 2008
29. Wu WH, Yang L, Peng FH, Yao J, Zou LL, Liu D, Jiang X, Li J, Gao L, Qu JM, Kawut SM, Jing ZC: Lower socioeconomic status is associated with worse outcomes in pulmonary arterial hypertension. Am J Respir Crit Care Med 187: 303–310, 2013
30. Benza RL, Gomberg-Maitland M, Miller DP, Frost A, Frantz RP, Foreman AJ, Badesch DB, McGoon MD: The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension. Chest 141: 354–362, 2012